에 대한 최신 뉴스 Nova (NASDAQ:NVMI) 주식

Nova

Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.

Nova Measuring

Equities

Large Cap

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

Tech

ETFs

AAPL

ACLS

AVGO

MSFT

NVDA

NVMI

OLED

QRVO

SOXQ

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

인공 지능의 추진에 힘입어 반도체 기업들의 주가가 고공행진을 이어가고 있는 가운데, 현재 미국 칩 제조 산업은 총 가치가 6조 3천억 달러에 달한다. Invesco PHLX 반도체 ETF(NYSE:SOXQ)가 반영하는 필라델피아 반도체 지수(PHLX Semiconductor Sector Index)는 이번 주에 6% 상승할 것으로 예상되어 두 달 만에 가장 강력한 실적을 기록하고 사상 최고 수준을 달성했다.

반도체 업계가 $6조 3천억에 도달, 사상 최고 기록: 이번 주 엔비디아를 앞선 5개의 칩 주식

Nova Ltd

BofA Securities analyst Vivek Arya previewed fourth-quarter earnings for semiconductor capital equipment&nbsp;(semicap), where reporting kicks off with ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>), Lam Research Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) on January 29 and&nbsp;&nbsp;KLA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) on January 30.
Subsector sentiment has broadly improved year-to-date, but Arya noted multiple nuances further complicated by the fallout from DeepSeek&#8217;s possible breakthrough. On one hand, the analyst noted risks like lower AI-related spending if DeepSeek&#8217;s R1 translates to lower compute demand for LLMs, capex cuts across memory (Micron Technology, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mu#NASDAQ">MU</a>), SK Hynix, Samsung) and Samsung Foundry and consensus estimates still appear high relative to industry growth expectations.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43200948/slm-growth-drivers-expense-control-and-market-share-gains-highlighted-by-analysts" rel="noreferrer noopener">SLM&#8217;s Loan Growth And Expense Control In Focus, Analysts Adjust Price Forecasts</a>
However, and more positively, he noted if DeepSeek means inference is more economical to perform at the edge, it could catalyze a PC/smartphone device upgrade cycle, which would support leading-edge Wafer Fab Equipment (WFE), December&#8217;s China export restrictions less onerous than expected, Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) calendar 2025 capex beat &amp; long-term AI sales CAGR of +40% (positive for complexity drivers), and Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) capex plans intact.
Amidst these moving parts, Arya noted that his $105 billion WFE view for calendar 2025 still holds and that he expects more alignment on these issues with upcoming reports. Given constructive recent data points for leading-edge foundry/logic and HBM spend, Arya raised his price targets for KLA Corp to $840 from $800, Nova Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) to $270 from $245, and Camtek Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) to $100 from $95, and reiterated his positive thesis for the cohort given tech inflection-led growth and strong free cash flow generation.
Arya also raised China WFE this year to $31.5 billion (now down -15% Y/Y) as local Chinese semicaps gain share. The analyst noted that leading-edge foundry/logic and HBM spending are the most robust and favor exposure there.
Consensus estimates for the top 5 semicaps model 10% Y/Y combined growth for calendar 2025 versus 12% Y/Y in early December. While expectations appear more reasonable, this is still above Arya&#8217;s +5% WFE forecast. Ex-ASML, top semicap growth is 8% (versus 11% prior). The analyst&#8217;s combined forecast for Applied Materials, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), Lam Research and KLA Corp are +7.2% Y/Y.
Even after the DeepSeek sell-off, semicap stocks have outperformed the sector year-to-date with Nova Ltd (+13%), KLA Corp (+12%), Applied Materials (+10%), Camtek Ltd (+6%), and Lam Research (+5%) all ahead of the SOX (down 3% year-to-date).
Valuation ranging from 19-30 times NTM P/E has been re-rated to catch up with emerging anticipations for WFE growth, but it is still attractive given that $150 billion WFE by calendar 2030-32 implies +7.5% long-term CAGR, tech inflection-led growth accelerates calendar 2025, and superior 20%- 36% FCF margins versus a median of 14% for S&amp;P 500 industrial companies.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/43197956/qualcomm-gains-2-billion-boost-from-samsung-s25-chipset-deal-analyst-highlights-growth-in-handsets-and-beyond" target="_blank" rel="noreferrer noopener">Qualcomm Gains $2 Billion Boost From Samsung S25 Chipset Deal, Analyst Highlights Growth in Handsets and Beyond</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

News

Price Target

Reiteration

Analyst Ratings

Trading Ideas

AMAT

ASML

CAMT

INTC

KLAC

LRCX

DeepSeek Sell-off Offers Opportunities On Semicaps, Analyst Bumps Up Price Forecasts For KLA, Nova And Camtek

WIIM

ACMR

ALAB

AMBA

AMKR

AOSL

ATOM

CRDO

ENTG

FORM

HIMX

ICHR

KLIC

LAES

LEDS

MKSI

MTSI

NVTS

ONTO

Penguin Solutions, Inc. - Ordinary Shares

PENG

QUIK

RGTI

RMBS

SITM

SKYT

SMTC

TSEM

UCTT

VECO

WOLF

Shares of semiconductor companies are trading lower amid AI competition concerns from China's DeepSeek AI model.

Cantor Fitzgerald analyst Matthew Prisco initiates coverage on Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Overweight rating and announces Price Target of $275.

Initiation

Cantor Fitzgerald Initiates Coverage On Nova with Overweight Rating, Announces Price Target of $275

Nova shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised its price target from $226 to $240.

Citigroup analyst Atif Malik upgrades Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) from Neutral to Buy and raises the price target from $226 to $240.

Upgrades

Citigroup Upgrades Nova to Buy, Raises Price Target to $240

<ul>
<li>Expands applications' reach to&nbsp;backend semiconductor and Wafer Level Packaging, including Advanced Packaging.</li>
<li>All-cash transaction valued at approximately $60 million.</li>
<li>Acquisition expected to be accretive on non-GAAP net earnings basis within 12 months of closing.</li>
</ul>
REHOVOT, Israel, Nov. 27, 2024 /PRNewswire/ -- Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>)&nbsp;announced today that&nbsp;it has&nbsp;entered into a definitive&nbsp;agreement&nbsp;to acquire Sentronics Metrology GmbH, a privately held company headquartered in Mannheim Germany, in an all-cash transaction&nbsp;valued at&nbsp;approximately $60 million.

Nova Acquires Sentronics Metrology To Expand Its Dimensional Metrology Portfolio, In An All-Cash Transaction Valued At ~$60M

Benchmark analyst Mark Miller maintains Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Buy and raises the price target from $240 to $245.

Benchmark Maintains Buy on Nova, Raises Price Target to $245

Needham analyst Charles Shi reiterates Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Hold.

Needham Reiterates Hold on Nova

Nova shares are trading higher after the company reported better-than-expected Q3 EPS and sales and provided Q4 revenue and EPS guidance above analyst estimates.

2024 Fourth Quarter Financial Outlook
Management provided an outlook for the fourth quarter, the period ending December 31, 2024. Based on current estimates, management expects:
<ul>
<li>$181 million to $191 million in revenue</li>
<li>$1.51 to $1.70 in diluted GAAP EPS</li>
<li>$1.72 to $1.91 in diluted non-GAAP EPS</li>
</ul>

Guidance

Nova Expects Q4 Revenue Of $181M-$191M Vs $171.84M Est, Adj EPS Of $1.72-$1.91 Vs $1.68 Est

Earnings

Earnings Beats

Nova Q3 2024 Adj. EPS $1.74 Beats $1.68 Estimate, Sales $178.974M Beat $171.840M Estimate

ARM,QCOM,NVDA,MU,AMD,TSM,AVGO,NXPI,LRCX,INTC,ASML,ON,RMBS,LSCC,GFS,TSEM,SIMO,ADI,KLAC,MCHP,STM,AMAT

ALGM

FSLR

LSCC

MCHP

MPWR

NXPI

QCOM

SIMO

Shares of chip stocks are trading lower in sympathy with ASML, which fell after issuing soft guidance. Some stocks in the sector may also be down on reports indicating the US is discussing curbing chip exports to some countries.

AEHR

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

SWKS

Shares of semiconductor companies are trading higher amid overall market strength following Wednesday's Fed rate cut.

Nova shares are trading lower after Citigroup downgraded the stock from Buy to Neutral and lowered its price target from $273 to $224.

Citigroup analyst Atif Malik downgrades Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) from Buy to Neutral and lowers the price target from $273 to $224.

Downgrades

Citigroup Downgrades Nova to Neutral, Lowers Price Target to $224

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Monday.
Shares of iTeos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) fell sharply in <a href="https://www.benzinga.com/quote/ITOS/analyst-ratings">today's pre-market trading.</a>
The company announced follow-up interim data from GALAXIES Lung-201.
iTeos Therapeutics shares dipped 13.7% to $14.40 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Vizsla Silver Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VZLA#NASDAQ">VZLA</a>) shares fell 11.4% to $1.94 in pre-market trading. Vizsla Silver announced a $65 million bought deal financing.</li>
<li>Murano Global Investments Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNO#NASDAQ">MRNO</a>) shares tumbled 11.1% to $8.89 in pre-market trading after jumping 36% on Friday.</li>
<li>Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) shares fell 8.5% to $34.79 in pre-market trading. Upstart announced a proposed private offering of $300,000,000 of convertible senior notes due 2029.</li>
<li>Guardant Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) shares dipped 8.2% to $24.60 in pre-market trading after gaining around 5% on Friday.</li>
<li>Hyliion Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYLN#NYSE">HYLN</a>) shares fell 6.7% to $1.96 in pre-market trading after gaining 8% on Friday. Hyliion Holdings, last week, announced it has been awarded a $15 million + contract by the Office of Naval Research to develop its KARNO generator for Navy ships and stationary power applications.</li>
<li>Instil Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) shares declined 6.1% to $79.40 in pre-market trading. Instil Bio and ImmuneOnco announced a global registrational strategy for PD-l1xvegf bispecific antibody, SYN-2510/IMM2510, in non-small cell lung cancer and triple-negative breast cancer.</li>
<li>Canaan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) fell 5.6% to $1.01 in pre-market trading after jumping 15% on Friday.</li>
<li>Solid Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) shares slipped 3% to $7.70 in pre-market trading after adding around 3% on Friday.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) shares fell 3% to $200.64 in pre-market trading.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares slipped 2.4% to $138.10 in pre-market trading amid a drop in the price of Bitcoin. MicroStrategy shares gained over 8% on Friday after the company announced the purchase of 18,300 bitcoin.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40860420/jim-cramer-hold-on-to-builders-firstsource-heres-the-problem-with-viking-therapeutics">Jim Cramer: &#8216;Hold On&#8217; To Builders FirstSource, &#8216;Here&#8217;s The Problem&#8217; With Viking Therapeutics</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

HYLN

ITOS

MRNO

MSTR

SLDB

UPST

VZLA

iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM).
Nikola shares dipped 10.4% to $7.28 on Monday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) shares jumped 103% to $0.6719. Sify becomes first in India to achieve NVIDIA DGX-ready data center certification for liquid cooling to enable breakthrough AI performance.</li>
<li>BranchOut Food Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOF#NASDAQ">BOF</a>) gained 85% to $3.70.</li>
<li>SPAR Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRP#NASDAQ">SGRP</a>) surged 65% to $2.3950 after the company announced it entered into a definitive agreement to be acquired by Highwire Capital for $2.50 per share.</li>
<li>Asset Entities Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) rose 62.7% to $2.31.</li>
<li>Conifer Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNFR#NASDAQ">CNFR</a>) shares jumped 56% to $1.0250 after the company announced that it completed the sale of its insurance agency operations for a $45 million consideration. The company appointed Brian Roney as CEO.</li>
<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) gained 44.6% to $1.25 after the company announced it recently launched both Apple CarPlay and Android Auto interfaces for its faidr mobile application.</li>
<li>Vaxcyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) surged 43.5% to $115.92 after the company announced it selected VAX-31 to advance to an adult Phase 3 program following topline results from its Phase 1/2 study.</li>
<li>Sable Offshore Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOC#NYSE">SOC</a>) gained 28.8% to $21.69.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) rose 21.8% to $6.57 after the company received a favorable legal ruling from the U.S. ITC in its patent infringement complaint against Voltage, LLC and a related foreign entity.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) jumped 17.5% to $6.55 after the company announced it dosed 5 new patients in its ACHIEVE Phase 2b trial.</li>
<li>AGM Group Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>) rose 16.5% to $1.27.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) gained 16% to $1.4150 after the company appointed former Stellantis executive Jean-Francois Mady as its new CFO.</li>
<li>Chemomab Therapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMMB#NASDAQ">CMMB</a>) surged 15.8% to $2.34.</li>
<li>MediciNova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNOV#NASDAQ">MNOV</a>) gained 15.3% to $1.73. MediciNova recently announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers MN-166 for post-COVID conditions.</li>
<li>GD Culture Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>) rose 12.8% to $6.86.</li>
<li>Big Tree Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSY#NASDAQ">DSY</a>) jumped 12.6% to $5.99.</li>
<li>Avalo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) gained 11.4% to $8.29.</li>
<li>Motorsport Games Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) rose 11.3% to $1.3250.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) gained 10.7% to $12.57 after Raymond James upgraded the stock from Market Perform to Outperform and announced a $17 price target.</li>
<li>Unity Software Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) gained 9.4% to $17.91 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.</li>
<li>Intchains Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) climbed 8.1% to $7.89.</li>
<li>Keros Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) gained 8.1% to $49.04 after the company announced an update on enrollment in the Phase 2 TROPOS trial.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) gained 4.5% to $12.94. Friday, the FDA granted Emergency Use Authorization to Novavax Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) for active immunization to prevent COVID-19 in individuals aged 12 and older.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares dipped 42.2% to $4.68.</li>
<li>Dyne Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) fell 31.7% to $31.47. The company announced new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy who are amenable to exon 51 skipping demonstrating unprecedented dystrophin expression and functional improvement in multiple cohorts.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares fell 31.3% to $1.75 after jumping 60% on Friday.</li>
<li>IO Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>) dipped 29.3% to $1.06 after the company announced the IDMC observed no new safety signals in the Phase 3 trial of IO102-IO103. Also, Morgan Stanley maintained an Overweight rating on the stock but lowered its price target from $7 to $4.</li>
<li>Brenmiller Energy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNRG#NASDAQ">BNRG</a>) fell 25.8% to $1.1499. Brenmiller recently reported a year-over-year increase in H1 EPS results. Also, the company announced a projected pipeline valued up to $500 million.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) dipped 22.8% to $1.13.</li>
<li>Four Seasons Education (Cayman) Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FEDU#NYSE">FEDU</a>) fell 21.8% to $13.30.</li>
<li>Quantum BioPharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>) declined 21.6% to $3.55.</li>
<li>Applied DNA Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) fell 18.8% to $1.5506.</li>
<li>Xiao-I Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) dipped 18.6% to $3.99.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) fell 16.1% to $8.49.</li>
<li>LightInTheBox Holding Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NASDAQ">LITB</a>) declined 14.3% to $0.4455.</li>
<li>NovoCure Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) fell 12.7% to $16.97 as the company announced planned CEO transition.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) fell 10.8% to $4.2350.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) declined 9.6% to $202.16.</li>
<li>Tidewater Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDW#NYSE">TDW</a>) fell 8.5% to $81.15.</li>
<li>Sterling Infrastructure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) fell 8.5% to $109.35.</li>
<li>The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) fell 8.3% to $159.27 ahead of the September 12 expiration of the company&#8217;s contract with the International Association of Machinists, which could lead to a potential strike. Additionally, Wells Fargo downgraded the stock from Equal-Weight to Underweight.</li>
<li>Avis Budget Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) dipped 8% to $75.43.</li>
<li>Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) fell 7.2% to $70.73.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) declined 7% to $20.52.</li>
<li>Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) fell 6.2% to $185.01.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40683473/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>

Intraday Update

AAOI

AGMH

AIXI

APDN

ASST

ATPC

AUUD

AVTX

BNRG

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

CNFR

FEDU

GERN

IOBT

KROS

LITB

MNOV

MRVL

MSGM

NVAX

NVCR

PCVX

PSNY

QNTM

RXRX

SGRP

SHLS

SIFY

SLXN

STRL

TCBP

WINT

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

ASTI

DIOD

ENPH

INDI

PLAB

POWI

SEDG

SLAB

SYNA

Shares of semiconductor stocks are trading lower amid overall market weakness. A drop in the price of NVIDIA may weigh down the sector.

Benchmark analyst Mark Miller maintains Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Buy and raises the price target from $215 to $240.

Benchmark Maintains Buy on Nova, Raises Price Target to $240

U.S. stocks were higher, with the Dow Jones index gaining over 1% on Thursday.
Shares of Parker-Hannifin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) rose sharply during Thursday's session following better-than-expected fourth-quarter financial results and <a href="https://www.benzinga.com/quote/PH">upbeat FY25 guidance.</a>
Parker Hannifin reported fourth-quarter sales growth of 2% year over year to $5.186 billion and +3% organic growth, beating the consensus of $5.082 billion.
Parker-Hannifin shares jumped 9.8% to $562.79 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) gained 42.2% to $25.27 after the company reported better-than-expected first-quarter financial results.</li>
<li>XPEL, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEL#NASDAQ">XPEL</a>) gained 35% to $42.65 after the company reported better-than-expected second-quarter financial results.</li>
<li>AxoGen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) shares surged 33.5% to $10.57 after the company reported better-than-expected second-quarter results.</li>
<li>CommScope Holding Company, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) climbed 30% to $2.7600 after the company reported better-than-expected second-quarter financial results.</li>
<li>DocGo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCGO#NASDAQ">DCGO</a>) rose 27.1% to $3.80 after the company reported better-than-expected quarterly sales.</li>
<li>Klaviyo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) gained 25.2% to $28.91 after the company reported better-than-expected second-quarter financial results. Also, the company issued FY24 and Q3 revenue guidance above estimates.</li>
<li>Leslie&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) rose 23.3% to $3.4050 following upbeat quarterly earnings.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) gained 19.6% to $26.90 following second-quarter results.</li>
<li>Clean Energy Fuels Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) gained 19.2% to $2.8850 following quarterly earnings.</li>
<li>ICU Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICUI#NASDAQ">ICUI</a>) jumped 18.1% to $143.88 following strong quarterly results.</li>
<li>Under Armour, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UA#NYSE">UA</a>) gained 17.2% to $7.35 following first-quarter earnings.</li>
<li>SharkNinja, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) rose 16% to $84.65 after the company reported better-than-expected quarterly financial results.</li>
<li>Zillow Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>) gained 15.5% to $46.61 after the company reported better-than-expected quarterly financial results.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) jumped 15% to $208.24 after the company reported better-than-expected second-quarter financial results and issued third-quarter guidance above estimates.</li>
<li>YETI Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) gained 13.1% to $41.90 after the company reported better-than-expected second-quarter financial results and raised its FY24 adjusted EPS guidance above estimates.</li>
<li>Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) rose 11.4% to $128.93 after the company reported better-than-expected first-quarter financial results.</li>
<li>Sealed Air Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEE#NYSE">SEE</a>) gained 10.6% to $38.04 following quarterly results.</li>
<li>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) rose 9.1% to $842.14 after the company reported better-than-expected second-quarter financial results and raised its full-year guidance.</li>
<li>ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) gained 5% to $69.63.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40253347/top-3-utilities-stocks-that-could-lead-to-your-biggest-gains-this-month">Top 3 Utilities Stocks That Could Lead To Your Biggest Gains This Month</a></li>
</ul>

AXGN

BOOT

CLNE

COMM

DCGO

FWRD

ICUI

KVYO

LESL

VSAT

XPEL

YETI

Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday

Nova (NVMI) announced that it has entered into a definitive agreement to acquire Sentronics Metrology GmbH, a privately held company headquartered ...

Nova to acquire Sentronics Metrology for $60M in cash

Nova (NVMI) has released an update. Nova Ltd. has announced its acquisition of Sentronics Metrology for approximately $60 million, aiming to expand...

Nova Expands Metrology Portfolio with Sentronics Acquisition

Nova (NVMI – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Mark Miller from Benchmark Co. ...

Strategic Acquisition of Sentronics Boosts Nova's Semiconductor Market Position: A Buy Rating Justification

In a report released today, Vivek Arya from Bank of America Securities maintained a Buy rating on Nova (NVMI – Research Report). The company's shar...

Nova (NVMI) Gets a Buy from Bank of America Securities

Nova ( ($NVMI) ) has issued an update. Nova announced its participation in the 27th Annual Needham Growth Conference, where its President and CEO, ...

Nova to Present at the 27th Annual Needham Growth Conference

Citi analyst Atif Malik upgraded Nova (NVMI) to Buy from Neutral with a price target of $240, up from $226. Published first on TheFly – the ultimat...

Nova upgraded to Buy from Neutral at Citi

Citi upgraded Nova (NVMI), Advanced Energy (AEIS), FormFactor (FORM), MKS Instruments (MKSI) (MSKI), and Veeco (VECO) to Buy from Neutral with pric...

Citi goes 'all in' on semi equipment, upgrades five to Buy

Cantor Fitzgerald initiated coverage of Nova (NVMI) with an Overweight rating and $275 price target Published first on TheFly – the ultimate source...

Nova initiated with an Overweight at Cantor Fitzgerald

Comments

Nova

뉴스

에 대한 최신 뉴스 Nova (NASDAQ:NVMI) 주식

금요일, 6월 14, 2024

뉴스

파트너 / 기고자

벤징가 글로벌